Early MRI Detection of Myocardial Deterioration as a Preventive, Disease Staging, and Prognostic Biomarker in Insulin Resistance
Trial ID or NCT#
NCT03509441
Status
NOT RECRUITING
Purpose
The purpose of this study is to evaluate the relationship between insulin resistance (IR) and myocardial tissue abnormalities. The study will focus on a patient population, South Asians, with a high prevalence of IR.
Official Title
Early MRI Detection of Myocardial Deterioration as a Preventive, Disease Staging, and Prognostic Biomarker in Insulin Resistance
Eligibility Criteria
Ages Eligible for Study: 20 Years to 60 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
- - South Asian
Exclusion Criteria:
- - Pregnant women - Patients with prior diagnoses of diabetes - Patients on insulin therapy - Patients with known coronary heart disease or other non-ischemic cardiomyopathies
Investigator(s)
Rajesh Dash, MD PhD; Director of SSATHI & CardioClick
Cardiologist
Associate Professor of Medicine (Cardiovascular Medicine)
Contact us to find out if this trial is right for you.
Contact
Krystal Solis
650-723-8138
View on ClinicalTrials.gov
